Comments on: Indian Court rules in favor of affordable drugs at expense of IP rights ? http://www.2point6billion.com/2007/08/10/indian-court-rules-in-favor-of-affordable-drugs-at-expense-of-ip-rights-272.html China & India, 40% of the world's population Wed, 07 Jan 2009 05:53:01 +0000 http://wordpress.org/?v=2.2-RC2 By: Mary http://www.2point6billion.com/2007/08/10/indian-court-rules-in-favor-of-affordable-drugs-at-expense-of-ip-rights-272.html#comment-7266 Mary Tue, 15 Jan 2008 14:12:09 +0000 http://www.2point6billion.com/2007/08/10/indian-court-rules-in-favor-of-affordable-drugs-at-expense-of-ip-rights-272.html#comment-7266 I found your blog by accident but am glad I did I found your blog by accident but am glad I did

]]> By: Raveen http://www.2point6billion.com/2007/08/10/indian-court-rules-in-favor-of-affordable-drugs-at-expense-of-ip-rights-272.html#comment-2986 Raveen Thu, 16 Aug 2007 14:16:53 +0000 http://www.2point6billion.com/2007/08/10/indian-court-rules-in-favor-of-affordable-drugs-at-expense-of-ip-rights-272.html#comment-2986 Can't fault the court here. R&D is an expensive affair but the profits generated by the pharma companies far outpace the expenses. A noble and moral alternative could have been for the pharma companies to take a bite off the profits however this defeats the purpose, for in business you work for profits. Catch 22 and thats where you have the government or the legislative step in to take a decision for the cause of people. Opens up a discussion on having geography based pricing i.e drugs price based on the earning levels in the developing countries. Can’t fault the court here. R&D is an expensive affair but the profits generated by the pharma companies far outpace the expenses. A noble and moral alternative could have been for the pharma companies to take a bite off the profits however this defeats the purpose, for in business you work for profits. Catch 22 and thats where you have the government or the legislative step in to take a decision for the cause of people.

Opens up a discussion on having geography based pricing i.e drugs price based on the earning levels in the developing countries.

]]>